Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 122 Pages
Report ld: 2700765
Request Sample
Customized Report
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
The global Mildronate Dihydrate market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In Europe, Mildronate Dihydrate key players include Grindeks, etc. Global top one manufacturers hold a share over 99%.
Russia is the largest market, with a share about 40%, followed by Latvia, and Lithuania, both have a share over 5 percent.
In terms of product, Capsule is the largest segment, with a share over 55%. And in terms of application, the largest application is Cardiovascular Disease, etc.
In terms of sales (consumption) side, this report focuses on the sales of Mildronate Dihydrate by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Mildronate Dihydrate market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Mildronate Dihydrate market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mildronate Dihydrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Mildronate Dihydrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mildronate Dihydrate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Mildronate Dihydrate Definition
1.2 Market by Type
1.2.1 Global Mildronate Dihydrate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Capsule
1.2.3 Injection
1.2.4 Tablet
1.3 Market Segment by Application
1.3.1 Global Mildronate Dihydrate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Disease
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Mildronate Dihydrate Sales
2.1 Global Mildronate Dihydrate Revenue Estimates and Forecasts 2019-2030
2.2 Global Mildronate Dihydrate Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Mildronate Dihydrate Revenue by Region
2.3.1 Global Mildronate Dihydrate Revenue by Region (2019-2024)
2.3.2 Global Mildronate Dihydrate Revenue by Region (2025-2030)
2.4 Global Mildronate Dihydrate Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Mildronate Dihydrate Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Mildronate Dihydrate Sales Quantity by Region
2.6.1 Global Mildronate Dihydrate Sales Quantity by Region (2019-2024)
2.6.2 Global Mildronate Dihydrate Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Mildronate Dihydrate Sales Quantity by Manufacturers
3.1.1 Global Mildronate Dihydrate Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Mildronate Dihydrate Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Mildronate Dihydrate Sales in 2023
3.2 Global Mildronate Dihydrate Revenue by Manufacturers
3.2.1 Global Mildronate Dihydrate Revenue by Manufacturers (2019-2024)
3.2.2 Global Mildronate Dihydrate Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mildronate Dihydrate Revenue in 2023
3.3 Global Mildronate Dihydrate Sales Price by Manufacturers
3.4 Global Key Players of Mildronate Dihydrate, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mildronate Dihydrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mildronate Dihydrate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mildronate Dihydrate, Product Offered and Application
3.8 Global Key Manufacturers of Mildronate Dihydrate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Mildronate Dihydrate Sales Quantity by Type
4.1.1 Global Mildronate Dihydrate Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Mildronate Dihydrate Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Mildronate Dihydrate Sales Quantity Market Share by Type (2019-2030)
4.2 Global Mildronate Dihydrate Revenue by Type
4.2.1 Global Mildronate Dihydrate Historical Revenue by Type (2019-2024)
4.2.2 Global Mildronate Dihydrate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Mildronate Dihydrate Revenue Market Share by Type (2019-2030)
4.3 Global Mildronate Dihydrate Price by Type
4.3.1 Global Mildronate Dihydrate Price by Type (2019-2024)
4.3.2 Global Mildronate Dihydrate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Mildronate Dihydrate Sales Quantity by Application
5.1.1 Global Mildronate Dihydrate Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Mildronate Dihydrate Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Mildronate Dihydrate Sales Quantity Market Share by Application (2019-2030)
5.2 Global Mildronate Dihydrate Revenue by Application
5.2.1 Global Mildronate Dihydrate Historical Revenue by Application (2019-2024)
5.2.2 Global Mildronate Dihydrate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Mildronate Dihydrate Revenue Market Share by Application (2019-2030)
5.3 Global Mildronate Dihydrate Price by Application
5.3.1 Global Mildronate Dihydrate Price by Application (2019-2024)
5.3.2 Global Mildronate Dihydrate Price Forecast by Application (2025-2030)
6 North America
6.1 North America Mildronate Dihydrate Sales by Company
6.1.1 North America Mildronate Dihydrate Revenue by Company (2019-2024)
6.1.2 North America Mildronate Dihydrate Sales Quantity by Company (2019-2024)
6.2 North America Mildronate Dihydrate Market Size by Type
6.2.1 North America Mildronate Dihydrate Sales Quantity by Type (2019-2030)
6.2.2 North America Mildronate Dihydrate Revenue by Type (2019-2030)
6.3 North America Mildronate Dihydrate Market Size by Application
6.3.1 North America Mildronate Dihydrate Sales Quantity by Application (2019-2030)
6.3.2 North America Mildronate Dihydrate Revenue by Application (2019-2030)
6.4 North America Mildronate Dihydrate Market Size by Country
6.4.1 North America Mildronate Dihydrate Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Mildronate Dihydrate Revenue by Country (2019-2030)
6.4.3 North America Mildronate Dihydrate Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Mildronate Dihydrate Sales by Company
7.1.1 Europe Mildronate Dihydrate Sales Quantity by Company (2019-2024)
7.1.2 Europe Mildronate Dihydrate Revenue by Company (2019-2024)
7.2 Europe Mildronate Dihydrate Market Size by Type
7.2.1 Europe Mildronate Dihydrate Sales Quantity by Type (2019-2030)
7.2.2 Europe Mildronate Dihydrate Revenue by Type (2019-2030)
7.3 Europe Mildronate Dihydrate Market Size by Application
7.3.1 Europe Mildronate Dihydrate Sales Quantity by Application (2019-2030)
7.3.2 Europe Mildronate Dihydrate Revenue by Application (2019-2030)
7.4 Europe Mildronate Dihydrate Market Size by Country
7.4.1 Europe Mildronate Dihydrate Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Mildronate Dihydrate Revenue by Country (2019-2030)
7.4.3 Europe Mildronate Dihydrate Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Mildronate Dihydrate Sales by Company
8.1.1 China Mildronate Dihydrate Sales Quantity by Company (2019-2024)
8.1.2 China Mildronate Dihydrate Revenue by Company (2019-2024)
8.2 China Mildronate Dihydrate Market Size by Type
8.2.1 China Mildronate Dihydrate Sales Quantity by Type (2019-2030)
8.2.2 China Mildronate Dihydrate Revenue by Type (2019-2030)
8.3 China Mildronate Dihydrate Market Size by Application
8.3.1 China Mildronate Dihydrate Sales Quantity by Application (2019-2030)
8.3.2 China Mildronate Dihydrate Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Mildronate Dihydrate Sales by Company
9.1.1 APAC Mildronate Dihydrate Sales Quantity by Company (2019-2024)
9.1.2 APAC Mildronate Dihydrate Revenue by Company (2019-2024)
9.2 APAC Mildronate Dihydrate Market Size by Type
9.2.1 APAC Mildronate Dihydrate Sales Quantity by Type (2019-2030)
9.2.2 APAC Mildronate Dihydrate Revenue by Type (2019-2030)
9.3 APAC Mildronate Dihydrate Market Size by Application
9.3.1 APAC Mildronate Dihydrate Sales Quantity by Application (2019-2030)
9.3.2 APAC Mildronate Dihydrate Revenue by Application (2019-2030)
9.4 APAC Mildronate Dihydrate Market Size by Region
9.4.1 APAC Mildronate Dihydrate Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Mildronate Dihydrate Revenue by Region (2019-2030)
9.4.3 APAC Mildronate Dihydrate Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mildronate Dihydrate Sales by Company
10.1.1 Middle East, Africa and Latin America Mildronate Dihydrate Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Mildronate Dihydrate Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Mildronate Dihydrate Market Size by Type
10.2.1 Middle East, Africa and Latin America Mildronate Dihydrate Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Mildronate Dihydrate Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Mildronate Dihydrate Market Size by Application
10.3.1 Middle East, Africa and Latin America Mildronate Dihydrate Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Mildronate Dihydrate Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Mildronate Dihydrate Market Size by Country
10.4.1 Middle East, Africa and Latin America Mildronate Dihydrate Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Mildronate Dihydrate Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Mildronate Dihydrate Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Grindeks
11.1.1 Grindeks Company Information
11.1.2 Grindeks Overview
11.1.3 Grindeks Mildronate Dihydrate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Grindeks Mildronate Dihydrate Products and Services
11.1.5 Grindeks Mildronate Dihydrate SWOT Analysis
11.1.6 Grindeks Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Mildronate Dihydrate Value Chain Analysis
12.2 Mildronate Dihydrate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mildronate Dihydrate Production Mode & Process
12.4 Mildronate Dihydrate Sales and Marketing
12.4.1 Mildronate Dihydrate Sales Channels
12.4.2 Mildronate Dihydrate Distributors
12.5 Mildronate Dihydrate Customers
13 Market Dynamics
13.1 Mildronate Dihydrate Industry Trends
13.2 Mildronate Dihydrate Market Drivers
13.3 Mildronate Dihydrate Market Challenges
13.4 Mildronate Dihydrate Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 71
USD 4250.00
(Single User License)
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 2900.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 85
USD 3950.00
(Single User License)
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 122
USD 4900.00
(Single User License)
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 116
USD 5900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 67
USD 4250.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 68
USD 2900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-16
Pages: 121
USD 5900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 71
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 95
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 85
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 122
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 116
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 67
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 68
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-16
Pages: 121
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-07
Pages: 71
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now